The Stock Target Advisor Blog

Get latest insights and news from the financial markets around the world

Piper Sandler raised Tesla(TSLA:NSD) to $1200

STA Research
by: STA Research

Piper Sandler restated its “overweight” recommendation on Tesla (NASDAQ:TSLA) in a research note sent to investors on...

Read More

JMP Securities raised Workday(WDAY:NSD) to $310

STA Research
by: STA Research

JMP Securities upped their target price on Workday Inc. from$296.00 to $310.00 and gave the company a “market outperform”...

Read More

Merck(MRK:NYE) SVB Leerink raised the target to $101 from $99

STA Research
by: STA Research

SVB Leerink maintained the Outperform rating on Merck & Co., and raised the target on the stock...

Read More

Raymond James Financial raised the target on Cameco(CCO:CA) Inc to $25 from $24

STA Research
by: STA Research

Raymond James Financial analyst Brian MacArthur raised the target on Cameco Inc to $25 from $24, and maintained...

Read More

Mizuho Securities raised the target on Pfizer(PFE:NYE) to $43 from $42

STA Research
by: STA Research

Mizuho Securities analyst Vamil Divan raised the target on Pfizer to $43 from $42 and maintained the...

Read More

National Bank Financial raised the target on Metro Inc.(MRU:TSX) to $66 from $65

STA Research
by: STA Research

National Bank Financial raised the target on Metro Inc. to $66 from $65 and maintained the Sector Perform...

Read More

Robinhood(HOOD:NSD) User Ratings have a average target of $19.26, and a Strong Sell Rating

STA Research
by: STA Research

Robinhood’s much anticipated IPO launched today with a muted response, with Atlantic Securities the only Investment firm...

Read More

National Bank Financial maintained Spinmaster(TOY:TSX) with Outperform rating and $56

STA Research
by: STA Research

National Bank Financial maintained the Outperform rating on Spin Master and $56 target on the stock, after...

Read More

Morgan Stanley raised Bristol Myers Squibb(BMY:NYE) to $71 from $62

STA Research
by: STA Research

Morgan Stanley raised the target on Bristol Myers Squibb to $71 from $62 and maintained the Equal Weight...

Read More